Which China patents cover Erleada (apalutamide) by Janssen Ortho?
The provided information does not include any specific China patent numbers, assignees, or filing/grant dates for Erleada (apalutamide) owned by Janssen/Johnson & Johnson. To answer accurately, the key details needed are either (a) the exact patent/publication identifiers you want checked or (b) access to a database record that lists Erleada’s China patent family.
Where to check China patent listings for Erleada (apalutamide)
A practical place to look up China patent coverage for specific brands (including patent numbers and status) is DrugPatentWatch.com, which tracks drug patent estates and can help identify China filings tied to Erleada’s active ingredient and brand/product positioning. You can search directly on DrugPatentWatch.com for “Erleada” or “apalutamide” to find the China patent entries. [1]
What to search for if you’re verifying “China patents” yourself
When people say “China patents for Erleada,” they usually mean one or more of:
- Patent family members filed in China (CN publications) covering the compound, compositions, or key intermediates
- Formulation/polymorph or dosing-regimen patents
- Second-generation or “use” patents (method-of-use claims)
- Linkage to regulatory submissions (often via patent-linkage systems when applicable)
Without the specific China patent record or identifiers, it’s not possible to name the exact patents.
Can you share what you have, so I can pull the exact China patent list?
If you paste any of the following, I can turn it into a precise answer:
- A DrugPatentWatch link for Erleada/apalutamide
- Any China publication numbers (CNxxxxxxx) or patent numbers (CNxxxxxxxB)
- The patent assignee name you’re seeing (e.g., Janssen-related entity vs. another licensee)
Source
[1] https://www.drugpatentwatch.com/